Findings indicate a 12.8% 10-year diabetes risk, driven by fasting plasma glucose, age, sex, and BMI, highlighting the need for targeted prevention strategies.
Genentech weighs slow-walking ovarian cancer therapy to make more money under drug pricing reform
WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they
August 10, 2023